EMGALITY
EMGALITY
Approved
DIN Number
02505134
Drug Class
Human
Market Date
Jan 11, 2021
Company
HC
eli lilly canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02505134
AIG Number0161690002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
N02CD02 GALCANEZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification28:32.12
Health Canada Classification
ACTIVE INGREDIENTS (1)
GALCANEZUMABActive
Strength: 100 MG / ML
Monograph: GALCANEZUMAB